Fiche publication
Date publication
septembre 2024
Journal
European heart journal
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves
Tous les auteurs :
Wang Y, Zeller M, Auffret V, Georgiopoulos G, Räber L, Roffi M, Templin C, Muller O, Liberale L, Ministrini S, Stamatelopoulos K, Stellos K, Camici GG, Montecucco F, Rickli H, Maza M, Radovanovic D, Cottin Y, Chague F, Niederseer D, Lüscher TF, Kraler S
Lien Pubmed
Résumé
and aims: Cardiogenic shock (CS) remains the primary cause of in-hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates approaching 50%. To test novel interventions, personalized risk prediction is essential. The ORBI (Observatoire Régional Breton sur l'Infarctus) score represents the first-of-its-kind risk score to predict in-hospital CS in ACS patients undergoing percutaneous coronary intervention (PCI). However, its sex-specific performance remains unknown, and refined risk prediction strategies are warranted.
Mots clés
C-reactive protein, LVEF, acute coronary syndromes, atherosclerosis, cardiogenic shock, gender medicine, inflammation, machine learning, multilayer perceptron, percutaneous coronary intervention, personalized risk prediction, precision medicine, random forest
Référence
Eur Heart J. 2024 09 1;: